Aug 06, 2024 / 08:30PM GMT
Operator
Good afternoon and welcome to the Supernus Pharmaceuticals' second-quarter 2024 financial results conference call. (Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of ICR Westwicke, Investor Relations Representative for Supernus Pharmaceuticals. You may begin now.
Peter Vozzo - Supernus Pharmaceuticals Inc - Investor Relations
Thank you, Corinne. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' second-quarter 2024 financial results conference call. Today, after the close of the market, the company issued a press release announcing these results.
On the call with me today are Supernus' Chief Executive Officer, Jack Khattar, and Chief Financial Officer, Tim Dec. Today's call is being made available via the Investor Relations section of the company's website at ir.supernus.com.
During the course of this call, management may make certain forward-looking statements regarding future events and the company's
Q2 2024 Supernus Pharmaceuticals Inc Earnings Call Transcript
Aug 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers